81 related articles for article (PubMed ID: 239132)
1. Pharmacokinetics of haloalkylamines: cyclization and distribution in blood in vitro and in vivo.
Ross SB
J Pharm Pharmacol; 1975 May; 27(5):322-8. PubMed ID: 239132
[TBL] [Abstract][Full Text] [Related]
2. Formation of a piperidinium derivative from N-(5'-chloropentyl)-N-methylaminoaceto-2,6-xylidide in relation to the sustained local anaesthetic action on the sciatic nerve of the guinea-pig in vivo.
Ross SB; Akerman SB
Nat New Biol; 1971 Apr; 230(17):274-5. PubMed ID: 5280667
[No Abstract] [Full Text] [Related]
3. Cyclization of three N- -haloalkyl-N-methylaminoaceto-2,6-xylidide derivatives in relation to their local anesthetic effect in vitro and in vivo.
Ross SB; Bengt S; Akerman A
J Pharmacol Exp Ther; 1972 Aug; 182(2):351-61. PubMed ID: 4538024
[No Abstract] [Full Text] [Related]
4. 1H NMR spectroscopic studies on the reactions of haloalkylamines with bicarbonate ions: formation of N-carbamates and 2-oxazolidones in cell culture media and blood plasma.
Anthony ML; Holmes E; McDowell PC; Gray TJ; Blackmore M; Nicholson JK
Chem Res Toxicol; 1995 Dec; 8(8):1046-53. PubMed ID: 8605287
[TBL] [Abstract][Full Text] [Related]
5. Formation of a quaternary derivative in mouse brain after administration of N-(5'-chloropentyl)-N-methylaminoaceto-2,6-xylidide.
Ross SB; Frödén O
Eur J Pharmacol; 1970; 13(1):46-50. PubMed ID: 5496927
[No Abstract] [Full Text] [Related]
6. Cyclizing compounds. I. Tertiary N-(2-bromobenzyl)-N-haloalkylamines with adrenergic blocking action.
Ross SB; Johansson JG; Lindborg B; Dahlbom R
Acta Pharm Suec; 1973 Mar; 10(1):29-42. PubMed ID: 4145284
[No Abstract] [Full Text] [Related]
7. Pharmacokinetics and metabolism of gabapentin in rat, dog and man.
Vollmer KO; von Hodenberg A; Kölle EU
Arzneimittelforschung; 1986 May; 36(5):830-9. PubMed ID: 3730018
[TBL] [Abstract][Full Text] [Related]
8. In vitro remifentanil metabolism: the effects of whole blood constituents and plasma butyrylcholinesterase.
Davis PJ; Stiller RL; Wilson AS; McGowan FX; Egan TD; Muir KT
Anesth Analg; 2002 Nov; 95(5):1305-7, table of contents. PubMed ID: 12401616
[TBL] [Abstract][Full Text] [Related]
9. Lorcainide. I. Saturable presystemic elimination.
Jähnchen E; Bechtold H; Kasper W; Kersting F; Just H; Heykants J; Meinertz T
Clin Pharmacol Ther; 1979 Aug; 26(2):187-95. PubMed ID: 455887
[No Abstract] [Full Text] [Related]
10. Tertiary 3- and 4-haloalkylamine analogues of oxotremorine as prodrugs of potent muscarinic agonists.
Ringdahl B; Roch M; Jenden DJ
J Med Chem; 1988 Jan; 31(1):160-4. PubMed ID: 3336014
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and tissue distribution of the new gastrokinetic agent cisapride in rat, rabbit and dog.
Michiels M; Monbaliu J; Hendriks R; Geerts R; Woestenborghs R; Heykants J
Arzneimittelforschung; 1987 Oct; 37(10):1159-67. PubMed ID: 3435588
[TBL] [Abstract][Full Text] [Related]
12. Plasma, whole blood and red blood cell kinetics of chloroquine after oral and parenteral administration in rabbits.
Salako LA; Adelusi SA
Arch Int Pharmacodyn Ther; 1983 Jan; 261(1):4-15. PubMed ID: 6847316
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of K-C1 cotransport in rat red cells by a hemolytic anemia-producing metabolite of dapsone.
Haas M; Harrison JH
Am J Physiol; 1989 Feb; 256(2 Pt 1):C265-72. PubMed ID: 2919657
[TBL] [Abstract][Full Text] [Related]
14. Cyclizing compounds. 3. Local anesthetic action of N-(omega-haloalkyl)-N-methylaminoaceto-2,6-xylidides.
Ross SB; Sandberg R; Akerman BA; Domeij KE; Stening G; Svensson S
J Med Chem; 1973 Jul; 16(7):787-90. PubMed ID: 4542166
[No Abstract] [Full Text] [Related]
15. Pharmacokinetic implications of slow equilibration of terbutaline between plasma and erythrocytes.
Borgå O; Lindberg C
Eur J Respir Dis Suppl; 1984; 134():73-80. PubMed ID: 6586488
[TBL] [Abstract][Full Text] [Related]
16. The metabolism of N-hydroxyphenacetin in vitro and in vivo.
Fischbach T; Lenk W
Xenobiotica; 1985 Nov; 15(11):915-27. PubMed ID: 4082632
[TBL] [Abstract][Full Text] [Related]
17. Single dose kinetics of mefloquine in man. Plasma levels of the unchanged drug and of one of its metabolites.
Schwartz DE; Eckert G; Hartmann D; Weber B; Richard-Lenoble D; Ekue JM; Gentilini M
Chemotherapy; 1982; 28(1):70-84. PubMed ID: 6976886
[TBL] [Abstract][Full Text] [Related]
18. Rapid biotransformation of satraplatin by human red blood cells in vitro.
Carr JL; Tingle MD; McKeage MJ
Cancer Chemother Pharmacol; 2002 Jul; 50(1):9-15. PubMed ID: 12111106
[TBL] [Abstract][Full Text] [Related]
19. Lorcainide. II. Plasma concentration-effect relationship.
Meinertz T; Kasper W; Kersting F; Just H; Bechtold H; Jähnchen E
Clin Pharmacol Ther; 1979 Aug; 26(2):196-204. PubMed ID: 455888
[No Abstract] [Full Text] [Related]
20. Cyclizing compounds. II. Tertiary N-(2-(2,6-dimethylphenoxy)ethyl)-N-haloalkylamines with local anaesthetic action.
Johansson JG; Lindborg B; Dahlbom R; Ross SB; Akerman B
Acta Pharm Suec; 1973 Jun; 10(3):199-208. PubMed ID: 4729696
[No Abstract] [Full Text] [Related]
[Next] [New Search]
